Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA||001B21A / 2||LA / IM|
Administered by: Private Purchased by: ??
Symptoms: Full blood count, Gestational diabetes, Haemorrhage in pregnancy, Pre-eclampsia, Protein urine, Ultrasound antenatal screen, Vaginal haemorrhage, Foetal non-stress test, Metabolic function test, Exposure during pregnancy, Blood loss anaemia
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4
Write-up: Estimated delivery date of August 5th, 2021. Currently 35 weeks. Development of preeclampsia, gestational diabetes at 34 weeks. 2 episodes of heavy vaginal bleeding during pregnancy, one at 30 weeks (just after 2nd dose of moderna vaccine) and one at 34 weeks. Currently being monitored for worsening preeclampsia with plans to deliver at 37 weeks (July 15, 2021) if stable. Gestational diabetes managed with diet and exercise at this time. Bleeding resolved within 2 or 3 days. Developed anemia after second bleeding episode.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166